Editorial Board
Editor-in-chief
Dr Emanuele Angelucci
Chair, Hematology and Cellular Therapy Unit, Ospedale Policlinico San Martino; Transplant Program Director, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genova, Italy
Editorial Board
Prof Khaled Musallam
Group Chief Research Officer, Burjeel Holdings; Deputy CEO and Chief of Cell & Gene Therapy and Hematology; Founding Director, Center for Research on Rare Blood Disorders; Director, Thalassemia & Sickle Cell Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, UAE; Adj. Professor, Khalifa University, Abu Dhabi, UAE; Adj. Professor, Weill Cornell Medicine, New York, USA
Dr Dimitar Efremov
Head, Molecular Hematology Unit, International Centre for Genetic Engineering & Biotechnology, Trieste, Italy
Dr David Gómez Almaguer
Head, Hematology Service, Hospital Universitario Dr. Jose E. González Universidad Autónoma de Nuevo León, Monterrey, México
Dr Dominique Bonnet
Senior Group Leader, Francis Crick Institute; Honorary Professor, Imperial College; Honorary Professor, Division of BioScience, University College London; Honorary Professor, Division of Hemato/Oncology, Department of Medicine King’s College, London, UK
Prof Loredana Bury
Section of Internal and Cadiovascular Medicina, Department of Medicine, University of Perugia, Perugia, Italy
Prof Sabri Kemahli
Professor of Pediatrics and Pediatric Hematology, Yeditepe University, Faculty of Medicine, Istanbul, Turkey; Alfaisal University College of Medicine, Riyadh, Saudi Arabia
Prof Ahmet Muzaffer Demir
Division of Hematology, Faculty of Medicine, Department of Medicine, Trakya University, Edirne, Turkey